An RF predistorter for base station HPAs of NADC system

This paper presents the design of an effective and low cost RF predistorter for use in the base-station high power amplifiers (HPAs) of the North American Digital Cellular (NADC) system. A complex polynomial is used to model the characteristic of the HPA and the predistorter generates the inband intermodulation (IM) products required for predistortion of the HPA. The design of the predistorter has a simple structure, using Schottky diodes as the nonlinear device to generate the inband IM products. Experimental results using a practical HPA show that the predistorter can reduce the adjacent-channel-power ratio (ACPR) of the pi/4-DQPSK signal used in the NADC system by 20 dB at an HPA output power level of 30 W. Moreover, the constellation and eye diagrams of the pi/4-DQPSK signal show that the predistorter can also reduce the signal distortion caused by the HPA. ©2009 IEEE.published_or_final_versio

An intermodulation products generator for predistortion of base station HPAs

This paper presents the design of an intermodulation (IM) products generator for predistortion of high-power amplifiers (HPAs) used in the base stations of cellular mobile systems. The IM products generator composes of two simple mixers constructed with Schottky diodes, has a simple structure and requires no external dc bias voltage. Simulation and measurement results show that the generator has a low conversion loss and low spurious frequency components. Studies of the IM3 generator for predistortion of a practical base station HPA are also carried out by simulation and measurements. Measurement result of a two-tone test shows that the predistorter can suppress the 3rd intermodulation distortion (IMD) products by 15 dB. ©2009 IEEE.published_or_final_versionThe IEEE Radio and Wireless Symposium (RWS 2009), San Diego, CA., 18-22 January 2009. In Proceedings of RWS, 2009, p. 602-60

A simple mixer for generating the 3rd-order intermodulation products used for HPA predistortion

This paper proposes to use nonlinear mixer circuits to generate the intermodulation (IM) products for high-power amplifier (HPA) predistortion using the difference-frequency technique. The design of a 3rd-order nonlinear circuit is used for illustration purpose. The circuit employs two mixers using Schottky diodes as non-linear devices to generate the differencefrequency signals. The circuit has a simple structure, requires no DC bias or additional filters, and is easy to fabricate and low cost. Simulation and measurement results show that the design has a low conversion loss and a low-frequency spurious. ©2009 IEEE.published_or_final_versionThe 9th International Symposium on Signals, Circuits and Systems (ISSCS 2009), Iasi, Romania, 9-10 July 2009. In Proceedings of the International Symposium on Signals, Circuits and Systems, 2009, p. 1-

A wideband 360° analog phase shifter design

This paper proposes a reflection-type wideband 360° analogue phase shifter. The phase shifter employs a branch-line coupler circuit to achieve a wideband operation and a varactor-diode circuit to achieve a wide phase-shift range. Analytical formulas are derived to optimize the parameters in the coupler circuit for wideband operation and reduced attenuation ripple, and in the varactor circuit to minimize the frequency dependency of the output phase. Simulation results using the Advanced Design Systems (ADS 2005A) show that the design has a wide bandwidth, wide phase shift range, and low attenuation ripple, and is highly linear across the operation bandwidth. ©2009 IEEE.published_or_final_versionThe 22nd IEEE Canadian Conference on Electrical and Computer Engineering (CCECE 2009), St. John's, NL., 3-6 May 2009. In Proceedings of the 22nd CCECE, 2009, p. 524-52

Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis

<p>Abstract</p> <p>Background</p> <p>Praziquantel has been used as first-line drug for chemotherapy of schistosomiasis since 1984. Besides praziquantel, artemether and artesunate have also been used for the control of this infectious disease since late 1990s. In this article, we conducted a systematic review and meta-analysis to evaluate the antischistosomal efficacy of different medication strategies including monotherapy or combination therapies of these drugs.</p> <p>Results</p> <p>A number of 52 trials from 38 articles published in peer-reviewed journals before July 2011 were selected for analysis after searching the following literature databases: the Cochrane Library, PubMed/Medline, ISI Web of Science, Chinese Biomedicine Literature Database, and China National Knowledge Infrastructure. Our meta-analyses showed that a dosage of 30-60 mg/kg praziquantel compared with placebo produced a protection rate of about 76% (95% CI: 67%-83%) for treating human schistosomiasis, which varied from 70% to 76% with no significant differences among the subspecies <it>S. haematobium</it>, <it>S. japonicum </it>or <it>S. mansoni</it>. Protection rates were higher when praziquantel doses were elevated, as concluded from the nRCTs results: the protection rate of praziquantel at 40 mg/kg was 52% (95% CI: 49%-55%), and it increased to 91% (95% CI: 88%-92%) when the dosages were elevated to 60/80/100 mg/kg divided two or more doses. Multiple doses of artemether or artesunate over 1- or 2-week intervals resulted in protection rates of 65% to 97% for preventing schistosomiasis, and increased doses and shorter medication intervals improved their efficacies. Praziquantel and artemisinin derivatives (artemether or artesunate) in combination resulted in a higher protection rate of 84% (95% CI: 64%-91%) than praziquantel monotherapy for treatment. praziquantel and artesunate in combination had a great protection rate of 96% (95% CI: 78%-99%) for preventing schistosomes infection.</p> <p>Conclusions</p> <p>According to the results, praziquantel remains effective in schistosomiasis treatment, and multiple doses would improve its efficacy; meanwhile, praziquantel is also a good drug for preventing acute schistosomiasis morbidity. It's better to use multiple doses of artemether or artesunate with 1- or 2-week intervals for prevention against schistosome infection. Praziquantel and artemether or artesunate in combination perform better in treatment than praziquantel monotherapy, and they are especially suitable for treating the patients with repeated exposure to infected water.</p

The problem of sharp notch in microstructured solids governed by dipolar gradient elasticity

In this paper, we deal with the asymptotic problem of a body of infinite extent with a notch (re-entrant corner) under remotely applied plane-strain or anti-plane shear loadings. The problem is formulated within the framework of the Toupin-Mindlin theory of dipolar gradient elasticity. This generalized continuum theory is appropriate to model the response of materials with microstructure. A linear version of the theory results by considering a linear isotropic expression for the strain-energy density that depends on strain-gradient terms, in addition to the standard strain terms appearing in classical elasticity. Through this formulation, a microstructural material constant is introduced, in addition to the standard Lamé constants . The faces of the notch are considered to be traction-free and a boundary-layer approach is followed. The boundary value problem is attacked with the asymptotic Knein-Williams technique. Our analysis leads to an eigenvalue problem, which, along with the restriction of a bounded strain energy, provides the asymptotic fields. The cases of a crack and a half-space are analyzed in detail as limit cases of the general notch (infinite wedge) problem. The results show significant departure from the predictions of the standard fracture mechanics

A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma

<p>Abstract</p> <p>Background</p> <p>The esophageal carcinoma related gene 4 (ECRG4) was initially identified and cloned from human normal esophageal epithelium in our laboratory (GenBank accession no.<ext-link ext-link-id="AF325503" ext-link-type="gen">AF325503</ext-link>). ECRG4 has been described as a novel tumor suppressor gene associated with prognosis in esophageal squamous cell carcinoma (ESCC).</p> <p>Methods</p> <p>In this study, binding affinity assay in vitro and co-immunoprecipitation experiment in vivo were utilized to verify the physical interaction between ECRG4 and transmembrane protease, serine 11A (TMPRSS11A, also known as ECRG1, GenBank accession no. <ext-link ext-link-id="AF 071882" ext-link-type="gen">AF 071882</ext-link>). Then, p21 protein expression, cell cycle and cell proliferation regulations were examined after ECRG4 and ECRG1 co-transfection in ESCC cells.</p> <p>Results</p> <p>We revealed for the first time that ECRG4 interacted directly with ECRG1 to inhibit cancer cell proliferation and induce cell cycle G1 phase block in ESCC. Binding affinity and co-immunoprecipitation assays demonstrated that ECRG4 interacted directly with ECRG1 in ESCC cells. Furthermore, the ECRG4 and ECRG1 co-expression remarkably upregulatd p21 protein level by Western blot (P < 0.001), induced cell cycle G1 phase block by flow cytometric analysis (P < 0.001) and suppressed cell proliferation by MTT and BrdU assay (both P < 0.01) in ESCC cells.</p> <p>Conclusions</p> <p>ECRG4 interacts directly with ECRG1 to upregulate p21 protein expression, induce cell cycle G1 phase block and inhibit cancer cells proliferation in ESCC.</p

Observation of a ppb mass threshoud enhancement in \psi^\prime\to\pi^+\pi^-J/\psi(J/\psi\to\gamma p\bar{p}) decay

The decay channel $\psi^\prime\to\pi^+\pi^-J/\psi(J/\psi\to\gamma p\bar{p})$ is studied using a sample of $1.06\times 10^8$ $\psi^\prime$ events collected by the BESIII experiment at BEPCII. A strong enhancement at threshold is observed in the $p\bar{p}$ invariant mass spectrum. The enhancement can be fit with an $S$-wave Breit-Wigner resonance function with a resulting peak mass of $M=1861^{+6}_{-13} {\rm (stat)}^{+7}_{-26} {\rm (syst)} {\rm MeV/}c^2$ and a narrow width that is $\Gamma<38 {\rm MeV/}c^2$ at the 90% confidence level. These results are consistent with published BESII results. These mass and width values do not match with those of any known meson resonance.Comment: 5 pages, 3 figures, submitted to Chinese Physics

Association of Mitochondrial DNA Haplogroups with Exceptional Longevity in a Chinese Population

BACKGROUND: Longevity is a multifactorial trait with a genetic contribution, and mitochondrial DNA (mtDNA) polymorphisms were found to be involved in the phenomenon of longevity. METHODOLOGY/PRINCIPAL FINDINGS: To explore the effects of mtDNA haplogroups on the prevalence of extreme longevity (EL), a population based case-control study was conducted in Rugao--a prefecture city in Jiangsu, China. Case subjects include 463 individuals aged > or = 95 yr (EL group). Control subjects include 926 individuals aged 60-69 years (elderly group) and 463 individuals aged 40-49 years (middle-aged group) randomly recruited from Rugao. We observed significant reduction of M9 haplogroups in longevity subjects (0.2%) when compared with both elderly subjects (2.2%) and middle-aged subjects (1.7%). Linear-by-linear association test revealed a significant decreasing trend of N9 frequency from middle-aged subjects (8.6%), elderly subjects (7.2%) and longevity subjects (4.8%) (p = 0.018). In subsequent analysis stratified by gender, linear-by-linear association test revealed a significant increasing trend of D4 frequency from middle-aged subjects (15.8%), elderly subjects (16.4%) and longevity subjects (21.7%) in females (p = 0.025). Conversely, a significant decreasing trend of B4a frequency was observed from middle-aged subjects (4.2%), elderly subjects (3.8%) and longevity subjects (1.7%) in females (p = 0.045). CONCLUSIONS: Our observations support the association of mitochondrial DNA haplogroups with exceptional longevity in a Chinese population